Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D02UJD
|
|||
Former ID |
DIB001806
|
|||
Drug Name |
PD-143188
|
|||
Synonyms |
PD-147693; PD-149394; PD-155144; PD-163637; PD-163639
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Psychotic disorder [ICD-11: 6A20-6A25] | Phase 2 | [1] | |
Company |
Parke-Davis & Co
|
|||
Structure |
Download2D MOL |
|||
Formula |
C24H27N
|
|||
Canonical SMILES |
C1CN(CC=C1C2=CC=CC=C2)CC3CC=CC(C3)C4=CC=CC=C4
|
|||
InChI |
1S/C24H27N/c1-3-9-21(10-4-1)23-14-16-25(17-15-23)19-20-8-7-13-24(18-20)22-11-5-2-6-12-22/h1-7,9-14,20,24H,8,15-19H2/t20-,24?/m1/s1
|
|||
InChIKey |
SDOHTVBFDDPWNE-CGHJUBPDSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005971) | |||
REF 2 | Anxiolytic effects of dopamine receptor ligands: I. Involvement of dopamine autoreceptors. Life Sci. 1998;62(7):649-63. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.